This episode features a round-up of the best of the first series of Cancer Research Matters.

It features some of the fantastic researchers that we have interviewed over the past year – including Professor Steve Jackson, Professor Ruth Plummer, Dr Simon Boulton, Professor Sir Leszek Borysiewicz, Professor Karen Vousden, Professor Richard Gilbertson and Professor Charles Swanton.

In this episode I tease out four themes that emerged over this first series that give some interesting insights into how we work as scientists, research leaders and research translators. 

Hosted on Acast. See acast.com/privacy for more information.

Cancer Research Matters, a new Podcast from Cancer Research UK featuring some of the incredible researchers behind cancer research. The idea is to drive and provoke conversation around cancer science, how it shapes our understanding of the disease and the challenges we face as we develop therapies.

The first series focusses on the 20th anniversary of CRUK – we’ll be winding back the clock on some of the great discoveries and breakthroughs made in the past two decades and asking some leading names where they think we’ll be in another 20 years.

This episode features Dr Simon Boulton. Simon is a leader in the field of DNA damage sensing, repair and telomere maintenance. He is Principal Group Leader and Assistant Research Director of translation at the Francis Crick Institute, and Director of RadNet, City of London – a CRUK initiative focused on improving radiation treatment for cancer patients. Simon is also co-founder and Vice President of Science Strategy of the spin-out Artios Pharma and Chair of CRUK’s Discovery Research Committee.

He talks about the dawn of the field of DNA damage repair, why an entrepreneurial approach to your research is so valuable and the importance of venture capital in the innovation landscape. 

Useful links

Explore the formation of Artios Pharma and the role of Cancer Research Horizons in translation

https://news.cancerresearchuk.org/2021/11/05/taking-on-dna-repair-to-tackle-cancer/

Explore RadNet. Whether you’re a cancer biologist, health professional, engineer or physical scientist, RadNet is an exciting and rewarding opportunity to apply your expertise and knowledge

https://www.cancerresearchuk.org/funding-for-researchers/our-research-infrastructure/radnet-our-radiation-research-network

Register your interest for the CRUK-ARR Radiation Research Conference https://forms.office.com/Pages/ResponsePage.aspx?id=L4lzROBx_EaN7Cc5ArUTSeNZ7IzS7O9ItRV1smdjkd1UMDBYRUI1SzRPSThYNTZEUDhSSzZSSUJKVi4u

Find out how Cancer Research Horizons can help you translate your work

https://www.cancerresearchhorizons.com/collaborate-us/researchers

Listen to Professor Steve Jackson on a previous episode

https://shows.acast.com/cancer-research-matters/episodes/translation-tales-20-years-of-forming-spinout

Hosted on Acast. See acast.com/privacy for more information.

This episode features Professor Charles Swanton. Charlie is Cancer Research UK's Chief Clinician and his lab at the Francis Crick Institute studies lung cancer tumour heterogeneity and maps the evolutionary pathways at work as cancers evolve and change.

He talks about the profound changes in the way the research community thinks about lung cancer, the power of the translational mind-set and delves into the flagship project, TRACERx.

He also talks briefly about his lab’s growing interest in the mechanistic links between air pollution and lung cancer in never smokers.

Useful links

Explore how Cancer Research Horizons can help you translate your work

https://www.cancerresearchhorizons.com/our-expertise/research-translation

Read about Charlie’s work on air pollution and lung cancer  https://news.cancerresearchuk.org/2021/12/13/its-a-fair-cop-why-our-chief-clinician-went-to-a-climate-change-summit/

ScottishPower and Cancer Research UK, working together for a greener, healthier future

Our longstanding partner ScottishPower is helping us shine a light on the role air pollution plays in cancer and are covering the cost of a study called TOPICAL. ScottishPower is 100% committed to helping tackle climate change and our partnership reflects our shared interest in a greener, healthier future.

Hosted on Acast. See acast.com/privacy for more information.